Technology | 2016.02.07
Crispr Gene-Editing Upstart Editas Goes Public as Patent Battle Rages - WIRED
| WIRED | Crispr Gene- Editing Upstart Editas Goes Public as Patent Battle Rages WIRED Right now, it's most successful as a experimental tool, editing the genomes of yeast cells and a worm here and there. But that's not stopping a number of biotech companies from capitalizing on the technology: Crispr Therapeutics, Caribou Biosciences ... Home > Current Issue > Gene Editing with CRISPR/Cas9 Corrects Mutation in Duchenne... CRISPR gene editing technique 'Edited' food: Is this obscure tool a game changer for GMOs? |
For more information, please visit
http://news.google.com/news/url?sa=t&fd=[...]pstart-editas-goes-public-as-p
